ClinConnect ClinConnect Logo
Search / Trial NCT07016776

Uroflowmetry Curve Types and IPSS in Men With LUTS

Launched by TARIK EMRE SENER · Jun 8, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

International Prostate Symptom Score (Ipss) Uroflowmetry Flow Curve Pattern Male Urinary Symptoms Prospective Observational Study

ClinConnect Summary

This clinical trial is studying how different patterns of urine flow, measured through a test called uroflowmetry, relate to the symptoms men experience with lower urinary tract issues, like trouble urinating or frequent urges, known collectively as lower urinary tract symptoms (LUTS). The researchers want to see how these flow patterns connect with survey results from a questionnaire called the International Prostate Symptom Score (IPSS), which helps assess the severity of urinary symptoms. By understanding these correlations, the study aims to improve clinical decisions for treating men with these conditions.

To join this study, participants need to be male, at least 40 years old, and experiencing LUTS. They should be able to complete the IPSS questionnaire and have had certain tests, including a urine flow test and blood work. However, men who have had prostate surgery, have a urinary tract infection, or use a urinary catheter cannot participate. If eligible, participants can expect to undergo standard medical evaluations and answer questions about their symptoms to help researchers gather valuable information for better treatment options.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • * Inclusion Criteria:
  • Male patients aged 40 years or older
  • Presenting with lower urinary tract symptoms (LUTS)
  • Able to complete the IPSS questionnaire
  • Underwent uroflowmetry and serum creatinine testing
  • Exclusion Criteria:
  • History of prior prostate surgery
  • Active urinary tract infection
  • Known diagnosis of neurogenic bladder
  • Current use of indwelling urinary catheter

About Tarik Emre Sener

Tarik Emre Sener is a dedicated clinical trial sponsor with a commitment to advancing medical research and improving patient outcomes. With a strong focus on innovative therapies and evidence-based practices, Sener leads initiatives that explore novel treatment options across various therapeutic areas. His expertise in clinical development, regulatory compliance, and strategic planning enables the successful execution of trials that adhere to the highest ethical and scientific standards. Through collaboration with healthcare professionals and research institutions, Tarik Emre Sener aims to bridge the gap between research and real-world application, ultimately contributing to the betterment of global health.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported